Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
QASDG External Expert
Francisco Tresserra was graduated in Medicine School at Barcelona University in 1988 and became specialist in Pathology in 1993 at the Hospital Mutua de Terrassa and obtained the Phd degree for the University of Barcelona in 1994 and since this year has been working in the Pathology Department of Hospital Universitario Dexeus, where actually is the Chief of Service since 2003.
He is the secretary of the Sociedad Española de Senologia y Patologia Mamaria (SESPM) and secretary of the Fundacion Española de Senología (FES).
One of his areas of interest is the breast pathology. He has published more than 80 papers in international journals, 60 of them cited in Pubmed. He has also participated in books chapter of breast pathology guides and specialized breast meetings.
He has stayed for short period at NIH and Armed Forces Institutes of Pathology in GYN and Breast pathology area. He also helps as a technical expert in pathology and cytology for the Entidad Nacional de Acreditacion (ENAC).